Literature DB >> 22868917

MicroRNA-200a and -200b mediated hepatocellular carcinoma cell migration through the epithelial to mesenchymal transition markers.

Chin-Sheng Hung1, Hui-Hsiung Liu, Jun-Jen Liu, Chi-Tai Yeh, Tung-Cheng Chang, Chih-Hsiung Wu, Yuan-Soon Ho, Po-Li Wei, Yu-Jia Chang.   

Abstract

BACKGROUND: MicroRNAs (miRNAs) play an essential role in mediating gene expression in both normal and malignant cells. However, little is known about specific miRNAs during the development of hepatocellular carcinoma (HCC) from well-differentiated to poorly differentiated cells.
METHODS: We performed miRNA array analysis of three different HCC cell lines: HepG2, HepJ5, and skHep-1. The expression patterns of miR-200 family members were confirmed by real-time polymerase chain reaction (PCR). We overexpressed miR-200 family members by using a lentivirus system and selected for stably transduced cells using antibiotics. The migration ability of the cells was tested using the Transwell migration assay system.
RESULTS: Our miRNA array and real-time PCR results indicated a decrease in the expression of miR-200 family members in poorly differentiated skHep-1 cells compared with well-differentiated HepG2 cells. We overexpressed miR-200a and miR-200b in both HepJ5 and skHep-1 cells and found that the overexpression of the miR-200 family members did not influence proliferation, although migration was decreased in these cells. We found that overexpression of miR-200 family members led to an upregulation of E-cadherin expression in both HepJ5 and skHep-1 cells. Furthermore, we silenced E-cadherin expression by shRNA in miR200a-HepJ5 cells and found that the migratory ability of these cells was enhanced upon the decrease in E-cadherin expression.
CONCLUSIONS: Members of the miR-200 family (miR-200a and miR-200b) play important roles in HCC migration by regulating E-cadherin expression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22868917     DOI: 10.1245/s10434-012-2482-4

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  20 in total

1.  Combination of exosomes and circulating microRNAs may serve as a promising tumor marker complementary to alpha-fetoprotein for early-stage hepatocellular carcinoma diagnosis in rats.

Authors:  Wei-hui Liu; Li-na Ren; Xing Wang; Tao Wang; Ning Zhang; Yuan Gao; Hao Luo; Nalu Navarro-Alvarez; Li-jun Tang
Journal:  J Cancer Res Clin Oncol       Date:  2015-02-28       Impact factor: 4.553

2.  MicroRNA-200a inhibits epithelial-mesenchymal transition in human hepatocellular carcinoma cell line.

Authors:  Chong Zhong; Ming-Yi Li; Zhi-Yuan Chen; Hai-Kun Cheng; Ming-Li Hu; Yue-Lu Ruan; Rong-Ping Guo
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

3.  miR-205 hinders the malignant interplay between prostate cancer cells and associated fibroblasts.

Authors:  Paolo Gandellini; Elisa Giannoni; Anna Casamichele; Maria Letizia Taddei; Maurizio Callari; Claudia Piovan; Riccardo Valdagni; Marco Alessandro Pierotti; Nadia Zaffaroni; Paola Chiarugi
Journal:  Antioxid Redox Signal       Date:  2013-09-17       Impact factor: 8.401

4.  MiR-200a enhances the migrations of A549 and SK-MES-1 cells by regulating the expression of TSPAN1.

Authors:  Yaqing Chen; Wei Peng; Yixiang Lu; Jianxin Chen; York Yuanyuan Zhu; Tao Xi
Journal:  J Biosci       Date:  2013-09       Impact factor: 1.826

Review 5.  Biomarkers for the early diagnosis of hepatocellular carcinoma.

Authors:  Nobuhiro Tsuchiya; Yu Sawada; Itaru Endo; Keigo Saito; Yasushi Uemura; Tetsuya Nakatsura
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

6.  Association of serum microRNA expression in hepatocellular carcinomas treated with transarterial chemoembolization and patient survival.

Authors:  Mei Liu; Jibing Liu; Liming Wang; Huiyong Wu; Changchun Zhou; Hongxia Zhu; Ningzhi Xu; Yinfa Xie
Journal:  PLoS One       Date:  2014-10-02       Impact factor: 3.240

7.  Investigating the pretreatment miRNA expression patterns of advanced hepatocellular carcinoma patients in association with response to TACE treatment.

Authors:  Medhat S El-Halawany; Heba M Ismail; Ahmed A Zeeneldin; Ammar Elfiky; Marwa Tantawy; Mohamed H Kobaisi; Ikram Hamed; Abdel Hady A Abdel Wahab
Journal:  Biomed Res Int       Date:  2015-02-25       Impact factor: 3.411

8.  All-trans retinoic acid reverses malignant biological behavior of hepatocarcinoma cells by regulating miR-200 family members.

Authors:  Jiejie Cui; Mengjia Gong; Shuyu Fang; Chaoqun Hu; Yi Wang; Jingfang Zhang; Ni Tang; Yun He
Journal:  Genes Dis       Date:  2020-01-10

Review 9.  MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma.

Authors:  Manuele Gori; Mario Arciello; Clara Balsano
Journal:  Biomed Res Int       Date:  2014-03-13       Impact factor: 3.411

10.  Downregulation of miR-200a induces EMT phenotypes and CSC-like signatures through targeting the β-catenin pathway in hepatic oval cells.

Authors:  Jie Liu; Bai Ruan; Nan You; Qike Huang; Weihui Liu; Zheng Dang; Weihua Xu; Ti Zhou; Ru Ji; Yang Cao; Xia Li; Desheng Wang; Kaishan Tao; Kefeng Dou
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.